Furthermore, ADRM1 also encodes RPN13, a critical ubiquitin receptor, and the application of inhibitors targeting the ADRM1/RPN13 interaction has been shown exert a substantial restraining effect on the amplification of ovarian cancer cell22. The gene discussed is ADRM1; the disease is ovarian carcinoma.